RBBP4 and malignant colon neoplasm: Overexpression of RBBP4 or HDAC1 correlates with clinicopathologic characteristics and poor prognosis in breast cancer17, and RBBP4 expression positively correlates with hepatic metastasis and poor prognosis in colon cancer patients18.